Related Experiment Videos
Genetic instability in primary leiomyosarcoma of bone
Sven J G Verelst1, Joachim Hans, Rainer G Hanselmann
1Flinders Department of Anatomical Pathology, Flinders Medical Centre, Adelaide, Australia.
Human Pathology
|January 26, 2005
Summary
Primary bone leiomyosarcoma (LMS) shows significant genetic instability, particularly in higher-grade tumors. Loss of heterozygosity and pRb inactivation are common, suggesting potential progression markers.
Area of Science:
- Oncology
- Genetics
- Sarcoma Research
Background:
- Primary bone leiomyosarcoma (LMS) is a rare bone tumor.
- Limited molecular data exists for intraosseous LMS.
- Understanding genetic alterations is crucial for prognosis.
Purpose of the Study:
- To investigate the genetic stability of primary bone LMS.
- To identify potential molecular markers for tumor progression.
- To correlate genetic findings with tumor grade and stage.
Main Methods:
- Microsatellite analysis at 7 loci to assess genetic stability.
- Immunostaining for hMLH1 and p53.
- Allelotyping for pRb.
- Analysis of human telomerase subunit-linked markers.
- Assessment of proliferation index.
Main Results:
- Grade IIB LMS tumors exhibited high genomic loss (up to 90%) and intratumoral heterogeneity.
- pRb inactivation was observed in all cases.
- p53 inactivation was present in 4 of 5 grade IIB tumors.
- Stage IIA tumor showed no genetic instability.
- Higher proliferation index in grade IIB tumors compared to grade IIA.
Conclusions:
- Intraosseous LMS may represent 'deletor phenotype' tumors.
- Loss of heterozygosity could serve as a progression marker.
- Genetic instability correlates with tumor grade and stage.